Back
ESC Professional Premium Access

Factors associated to renin-angiotensin-aldosterone system inhibitors discontinuation or down-titration due to hyperkalaemia in patients with chronic cardiovascular conditions

Session: Challenges in cardiovascular pharmacotherapy in patients who are older or with comorbidities
Topic: Angiotensin-Renin-Bradykinin System
Speaker: Ms L. Alcoberro (Hospitalet De Llobregat, ES)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Ms Lidia Alcoberro

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)
0 follower

7 more presentations in this session

The use of warfarin as part of antithrombotic strategy after transcutaneous aortic valve replacement is not associated with better medium-term outcomes

Speaker: Doctor J. Naser (Rochester, US)

Access
Abstract
Slides
Like
Thumbnail

Direct oral anticoagulants compared to vitamin K antagonists for the treatment of left ventricular thrombi

Speaker: Doctor H. Morgan (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Frailty and outcomes in octogenarians with atrial fibrillation treated with edoxaban: ESCAPE study

Speaker: Doctor G. Denas (Padova, IT)

Access
Abstract
Slides
Like
Thumbnail

Oral anticoagulant therapy and decline of kidney function in elderly patients with non-valve atrial fibrillation: real world evidence data

Speaker: Doctor G. Severini (Catanzaro, IT)

Access
Abstract
Slides
Like
Thumbnail

Previous antithrombotic therapy does not have an impact on the in-hospital mortality of patients with upper gastrointestinal bleeding

Speaker: Doctor M. Hozman (Prague, CZ)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Challenges in cardiovascular pharmacotherapy in patients who are older or with comorbidities

Speakers: Ms L. Alcoberro, Doctor J. Naser, Doctor H. Morgan, Doctor G. Denas, Doctor G. Severini...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources